IOLCP

What IOL Chemicals and Pharmaceuticals promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 19 tracked 3 delivered 3 missed 13 open
  • Capacity Utilization delivered said Q3 FY25 Promised: Hoping for that to increase to around 90% in the next two to three quarters. Q1 FY27: Maintained at 80-95%
  • Export Share revised down said Q4 FY25 Promised: Achieve the export realization or export sale of around 40% to 45% in the next 2 years. Q1 FY27: Q1 actual 28.5%. New FY27 guidance 25-30%, significantly below original 40-45% target.
  • EBITDA Margin missed said Q4 FY25 Promised: We are expecting more than 15% in the current year. Q4 FY26: FY26 actual: 12.4%. Original target >15% missed.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 19 tracked commitments for IOL Chemicals and Pharmaceuticals — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens